Immediate Impact

3 by Nobel laureates 4 from Science/Nature 52 standout
Sub-graph 1 of 24

Citing Papers

Dendritic cell maturation in cancer
2025 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
3 intermediate papers

Works of David Readett being referenced

Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
2011
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
2011
and 1 more

Author Peers

Author Last Decade Papers Cites
David Readett 178 63 70 287 106 17 554
Manuela Krokowski 90 79 48 363 52 25 648
Shahab Khan 203 48 23 122 47 19 468
Ruth Tyler 70 53 19 194 196 18 619
Michael R. Bishop 213 81 82 149 76 21 620
Carl E. Krill 121 66 85 73 199 24 608
Colvin Rb 28 14 79 184 114 21 584
Paula P.M.C. van Miert 35 184 26 240 118 18 609
Caterina Micò 127 282 22 82 186 18 599
Brigitte Adams 29 41 83 338 91 23 591
Silvia Tartari 217 13 8 385 147 18 562

All Works

Loading papers...

Rankless by CCL
2026